Ms Laxmi Jagadish, MS CCC-SLP | |
44 Milltown Rd, East Brunswick, NJ 08816-2356 | |
(732) 238-1664 | |
(732) 613-9795 |
Full Name | Ms Laxmi Jagadish |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 44 Milltown Rd, East Brunswick, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194891549 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | YS00263500 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Laxmi Jagadish, MS CCC-SLP 21 Dexter Rd, East Brunswick, NJ 08816-2873 Ph: (732) 651-3259 | Ms Laxmi Jagadish, MS CCC-SLP 44 Milltown Rd, East Brunswick, NJ 08816-2356 Ph: (732) 238-1664 |
News Archive
The likelihood of complications associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukaemia may be reduced by considering patient factors and differences in the toxicity profiles of the different drug options, a review suggests.
A new 'traffic light' test devised by Dr Nick Sheron and colleagues at University of Southampton and Southampton General Hospital could be used in primary care to diagnose liver fibrosis and cirrhosis in high risk populations more easily than at present.
A federal court judge dismissed a lawsuit Monday which was filed against the government by 14 Medicare beneficiaries who were denied nursing home coverage because they had been kept in the hospital under "observation status."
Poor air quality days significantly increase the risk of hospitalizations for respiratory issues in young survivors of cancer, according to a study conducted by researchers at Huntsman Cancer Institute at the University of Utah and published in the International Journal of Environmental Research and Public Health.
Affymax, Inc. and Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) today announced the presentation of post-hoc sub-group analyses of the EMERALD Phase 3 studies that evaluated OMONTYS (peginesatide) Injection, an erythropoiesis-stimulating agent (ESA), for the treatment of anemia due to chronic kidney disease (CKD) in adult dialysis patients.
› Verified 3 days ago
Mrs. Judy Adornati, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4 Cornwall Dr Ste 101, East Brunswick, NJ 08816 Phone: 732-210-7241 | |
Mrs. Jennifer Harmon, M.A. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 44 Milltown Rd, East Brunswick, NJ 08816 Phone: 732-238-1664 | |
Nicole Schultz, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Irene Ct, East Brunswick, NJ 08816 Phone: 732-201-7002 | |
Rewa Atre, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 579 Cranbury Rd Ste I, East Brunswick, NJ 08816 Phone: 732-313-5458 | |
Orit Binshtock, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 24 Bunker Hill Run, East Brunswick, NJ 08816 Phone: 732-322-4506 | |
Lauren Grandal, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 281 Summerhill Rd, East Brunswick, NJ 08816 Phone: 908-358-6064 | |
Miss Mary Ann Theresa Lombardo, M.A.;CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 394 Carhart Ct, East Brunswick, NJ 08816 Phone: 917-670-7862 |